US Stock MarketDetailed Quotes

MASS 908 Devices

Watchlist
  • 2.080
  • -0.040-1.89%
Close Dec 13 16:00 ET
  • 2.040
  • -0.040-1.92%
Post 20:01 ET
72.43MMarket Cap-1.16P/E (TTM)

About 908 Devices Company

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

Company Profile

SymbolMASS
Company Name908 Devices
Listing DateDec 18, 2020
Issue Price20.00
Founded2012
CEOMr. Kevin J. Knopp, PhD
MarketNASDAQ
Employees71
Fiscal Year Ends12-31
Address645 Summer Street,2nd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-254-1500

Company Executives

  • Name
  • Position
  • Salary
  • Kevin J. Knopp, PhD
  • President, Chief Executive Officer and Director
  • 1.45M
  • Christopher Brown, PhD
  • Chief Product Officer
  • --
  • Joseph H. Griffith,IV
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 1.22M
  • Michael Scott Turner
  • Chief Legal and Administrative Officer and Secretary
  • 1.17M
  • Don Osmer
  • Vice President, Human Resources
  • --
  • John Kenneweg
  • Vice President, Government
  • --
  • Dr. Kevin McCallion, PhD
  • Vice President, Production and New Product Introduction
  • --
  • Steve Davenport
  • Vice President, Commercial Sales
  • --
  • Barbara Russo
  • Vice President, Marketing and Corporate Communications
  • --
  • E. Kevin Hrusovsky
  • Chairman of the Board
  • 222.51K
  • Michele M. Leonhart
  • Director
  • --
  • Jeffrey P. George
  • Independent Director
  • 195.01K
  • Mark Spoto
  • Independent Director
  • 200.01K
  • Keith L. Crandell
  • Independent Director
  • 202.51K
  • Tony J. Hunt
  • Independent Director
  • 175.01K
  • Fenel M. Eloi
  • Independent Director
  • 195.01K
  • Dr. Marcia Eisenberg, PhD
  • Independent Director
  • 185.01K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.